Target intelligence / Profile preview

NADH:ubiquinone oxidoreductase subunit B1 pseudogene 2 (NDUFB1P2)

Target
NDUFB1P2
Molecular classification
Other (Pseudogene)
01

Overview

NADH:ubiquinone oxidoreductase subunit B1 pseudogene 2 (NDUFB1P2) is classified as a human **pseudogene**, meaning it is a segment of DNA similar to a functional gene (NDUFB1), but generally considered **non-coding and functionally inactive**[13][15]. Pseudogenes like NDUFB1P2 may arise from gene duplication or retrotransposition and usually **do not produce functional proteins**. This gene is not associated with any known enzyme activity, molecular function, or disease phenotype, and it is not considered a target for drugs or therapeutic intervention[13][15][11]. Biological function, disease roles, drug interactions, mechanisms of action, biomarkers, or notable safety concerns have not been identified for this pseudogene. **Key distinction:** While NDUFB1 (without the "P2" suffix) encodes a subunit of mitochondrial Complex I involved in the electron transport chain[1][2], NDUFB1P2 is only a non-functional, non-coding sequence. Its presence is mainly relevant to genomic annotation and evolutionary studies, not biomedical targeting or therapeutic development[13][15].

Other names
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1 pseudogene 2NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa pseudogeneNDUFB1P2

Beyond the preview

Go deeper on NADH:ubiquinone oxidoreductase subunit B1 pseudogene 2 (NDUFB1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B1 pseudogene 2 (NDUFB1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call